TCFG Investment Advisors’s AbbVie ABBV Stock Holding History

TCFG Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$217K	Buy	+862	New	+$185K	0.07%	273

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

TCFG Investment Advisors's ABBV Position: Q2 2026 in Review

TCFG Investment Advisors opened a new position in AbbVie (ABBV) in Q2 2026: 862 shares worth $217K. The stake represents 0.07% of the portfolio and ranks #273 among its holdings.

4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

TCFG Investment Advisors held 862 shares of AbbVie worth $217K as of Q2 2026.
AbbVie was a new TCFG Investment Advisors position in Q2 2026.
AbbVie made up 0.07% of TCFG Investment Advisors's portfolio in Q2 2026, its #273 holding.
4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on TCFG Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.